AIDX
20/20 Biolabs, Inc. Common Stock
NASDAQ · Healthcare · Medical - Devices · US
$0.59
−3.27%Sep 2, 2026, 19:15 UTC
BioLabs announced Carmen Schicklberger as site director for BioLabs Rochester, MN, and Geof Hannigan as Mayo Clinic's director of startup engagement.
Source:Sep 2, 2026, 19:15 UTC
BioLabs Rochester, MN announced it will open its 17,000-square-foot shared laboratory and office facility in September 2026, with recruitment underway for resident companies.
Source:Aug 17, 2026, 12:31 UTC
20/20 BioLabs reported its financial results for the second quarter ended June 30, 2026, with record quarterly revenue from its flagship multi-cancer early detection test, OneTest revenue up 47% year-over-year to $0.7 million, gross profit up 87% to $0.3 million, gross margin expanding to 41.7% from 30.5%, and cash position strengthened to $4.5 million with all convertible note debt eliminated during the quarter.
Source:Jul 23, 2026, 12:31 UTC
20/20 BioLabs entered into a standstill agreement with Streeterville Capital regarding its Series E Convertible Preferred Stock, temporarily restricting conversions below a defined price threshold to mitigate near-term dilution.
Source: